Cancer Epidemiology

Volume 1, Host Susceptibility Factors
Herausgegeben:Verma, Mukesh

• Broschiertes Buch

Produktbeschreibung

Population studies and epidemiology facilitate the discovery of genetic and environmental determinants of cancer and the development of new approaches to cancer control and prevention, therefore they play a central role in the creation of health policies. Cancer Epidemiology compiles areas of research which cover etiological factors or determinants that contribute to the development of cancer and describe the latest technologies in cancer epidemiology. In Volume 1, Host Susceptibility Factors, leading experts provide chapters on cancer incidence, prevalence, mortality and surveillance, methods, technologies and study design in cancer epidemiology as well as host susceptibility factors in cancer epidemiology. Although a non-standard volume of the highly successful Methods in Molecular Biology(TM) series, this comprehensive text retains the commitment of the series to collecting the kind of detailed, up-to-date information and implementation advice that is crucial for getting optimal results.

Cutting-edge and essential, Cancer Epidemiology allows readers to get the maximum advantage of the methods involved in this exciting and important field.

Produktdetails

• Methods in Molecular Biology 471
• Verlag: Humana / Humana Press / Springer, Berlin
• Artikelnr. des Verlages: 978-1-61737-868-3
• Softcover reprint of hardcover 1st ed. 2009
• Seitenzahl: 528
• Erscheinungstermin: 19. November 2010
• Englisch
• Abmessung: 280mm x 210mm x 29mm
• Gewicht: 1277g
• ISBN-13: 9781617378683
• ISBN-10: 1617378682
• Artikelnr.: 32459683

Inhaltsangabe

Cancer Incidence, Prevalence, Mortality and Surveillance.- Cancer Occurrence.- Cancer Registry Databases: An Overview of Techniques of Statistical Analysis and Impact on Cancer Epidemiology.- Breast Cancer in Asia.- Cancer Epidemiology in the United States: Racial, Social, and Economic Factors.- Epidemiology of Multiple Primary Cancers.- Cancer Screenings, Diagnostic Technology Evolution, and Cancer Control.- Thriving for Clues in Variations Seen in Mortality and Incidence of Cancer: Geographic Patterns, Temporal Trends, and Human Population Diversities in Cancer Incidence and Mortality.- Methods, Technologies and Study Design in Cancer Epidemiology.- Evaluation of Environmental and Personal Susceptibility Characteristics That Modify Genetic Risks.- to the Use of Regression Models in Epidemiology.- Proteomics and Cancer Epidemiology.- Different Study Designs in the Epidemiology of Cancer: Case-Control vs. Cohort Studies.- Methods and Approaches in Using Secondary Data Sources to Study Race and Ethnicity Factors.- Statistical Methods in Cancer Epidemiological Studies.- Methods in Cancer Epigenetics and Epidemiology.- Host Susceptibility Factors in Cancer Epidemiology.- Mitochondrial DNA Polymorphism and Risk of Cancer.- Polymorphisms of DNA Repair Genes: ADPRT, XRCC1, and XPD and Cancer Risk in Genetic Epidemiology.- Risk Factors and Gene Expression in Esophageal Cancer.- Single Nucleotide Polymorphisms in DNA Repair Genes and Prostate Cancer Risk.- Linking the Kaposi's Sarcoma-Associated Herpesvirus (KSHV/HHV-8) to Human Malignancies.- Cancer Cohort Consortium Approach: Cancer Epidemiology in Immunosuppressed Groups.- Do Viruses Cause Breast Cancer?.- Epidemiology of Human Papilloma Virus (HPV) in Cervical Mucosa.- Epigenetic Targets in Cancer Epidemiology.- Epidemiology of Lung Cancer Prognosis: Quantity and Quality of Life.- Hereditary Breast and Ovarian Cancer Syndrome.

Rezensionen

From the reviews:

"The first volume is dedicated to the methods, technologies and study design in analytical cancer epidemiology. ... the more thorough attention is provided to case-control and cohort studies, to regression models. ... In conclusion it is necessary ... for clinicians, epidemiologists and laboratory workers, studying molecular biology in acquisition of knowledges which could broaden their scientific outlook and enlarge the orientation of their study in future years." (I. Plesko, Neoplasma, April, 2009)